Authors: Schultz, ES Zhang, Y Knowles, R Tine, J Traversari, C Boon, T van der Bruggen, P

Citation: Es. Schultz et al., A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes, TISSUE ANTI, 57(2), 2001, pp. 103-109

Authors: Horig, H Lee, DS Conkright, W Divito, J Hasson, H LaMare, M Rivera, A Park, D Tine, J Guito, K Tsang, KWY Schlom, J Kaufman, HL

Citation: H. Horig et al., Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule, CANCER IMMU, 49(9), 2000, pp. 504-514

Authors: Sedegah, M Weiss, W Sacci, JB Charoenvit, Y Hedstrom, R Gowda, K Majam, VF Tine, J Kumar, S Hobart, P Hoffman, SL

Citation: M. Sedegah et al., Improving protective immunity induced by DNA-based immunization: Priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus, J IMMUNOL, 164(11), 2000, pp. 5905-5912

Authors: Luiten, RM Demotte, N Tine, J van der Bruggen, P

Citation: Rm. Luiten et al., A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 andHLA-A1 molecules, TISSUE ANTI, 56(1), 2000, pp. 77-81